Phase 3 PHOENYCS GO study met the primary endpoint demonstrating clinical improvement in moderate-to-severe systemic lupus erythematosus; Clinical improvements were observed among key secondary...
UCB Convening Notice to the General Meeting of the Shareholders 2024 CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS The Board of Directors invites the shareholders for the ordinary...
SOLANA BEACH, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) a global therapy-enabling platform company providing navigation and delivery to the brain, today...
UCB Convocation à L’ Assemblée Générale des Actionnaires 2023 CONVOCATION A L’ASSEMBLEE GENERALE DES ACTIONNAIRES Le Conseil d’Administration invite les actionnaires à l’assemblée générale...
BOSTON, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company, and UCB (EURONEXT BRUSSELS: UCB), a global...
UCB SA/NV - CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS 2022 Unofficial English translation – For convenience purposes only UCB SA/NV - Public Limited Liability CompanyAllée...
UCB SA - convocation à l'assemblée générale ordinaire UCB - Société AnonymeAllée de la Recherche 60, 1070 BruxellesN° d’entreprise 0403.053.608 (RPM Bruxelles)www.ucb.com(« UCB SA » ou...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -3.7 | -2.18870156758 | 169.05 | 169.2 | 160.3 | 224919 | 163.55165264 | DE |
4 | 1.75 | 1.06968215159 | 163.6 | 169.35 | 158.15 | 212598 | 162.98558538 | DE |
12 | 20.7 | 14.3104044245 | 144.65 | 169.35 | 137.15 | 211173 | 155.96893135 | DE |
26 | 51.25 | 44.916739702 | 114.1 | 169.35 | 112.65 | 247143 | 138.99242014 | DE |
52 | 87.53 | 112.477512208 | 77.82 | 169.35 | 65.4 | 284879 | 108.74190171 | DE |
156 | 67.27 | 68.586867863 | 98.08 | 169.35 | 65.4 | 272280 | 93.35538491 | DE |
260 | 102.07 | 161.298988622 | 63.28 | 169.35 | 60.18 | 299954 | 90.07770505 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales